# Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma

> **NCT02043860** · PHASE1 · TERMINATED · sponsor: **University of Illinois at Chicago** · enrollment: 3 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **RADIATION:** Total Marrow Irradiation
- **PROCEDURE:** Autologous Transplant
- **DRUG:** Melphalan
- **DRUG:** Filgrastim (G-CSF)

## Key facts

- **NCT ID:** NCT02043860
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01-10
- **Primary completion:** 2016-11-07
- **Final completion:** 2016-11-07
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2019-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02043860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02043860, "Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02043860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*